Effect of Cancer Nurse Navigators on Patient Outcomes

NCT ID: NCT01902823

Last Updated: 2019-12-13

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Clinical Phase

PHASE2/PHASE3

Total Enrollment

16 participants

Study Classification

INTERVENTIONAL

Study Start Date

2011-11-30

Study Completion Date

2012-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

There is widespread anecdotal evidence that Cancer Nurse Navigators (CNNs) are highly valued by cancer patients, but no studies have evaluated the effects of CNNs on important patient-reported outcomes or indicators of quality of care. This study has two aims:

1. To assess the feasibility of studying the impact of Aurora CNN Program.
2. To pilot test the effects of CNN services on patient-reported outcomes and indicators of quality of care.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Lung Cancer Breast Cancer Colorectal Cancer Prostate Cancer

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Nurse Navigator Satisfaction with Care Quality of Life Symptom Distress

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

No Nurse Navigator Services

Group Type NO_INTERVENTION

No interventions assigned to this group

Services from a Nurse Navigator

Group Type EXPERIMENTAL

Services from a Nurse Navigator

Intervention Type BEHAVIORAL

Services from a Nurse Navigator

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Services from a Nurse Navigator

Services from a Nurse Navigator

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Adult (18 years of age or older)
2. Treated at Aurora St. Luke's or West Allis Medical Center
3. New or recurrent dx of lung, prostate, colorectal or breast cancer -

Exclusion Criteria

1. Previously received CNN services at an Aurora treatment facility
2. Unable to read/write in English
3. Living in a nursing home/long term care facility
4. Not capable of completing study questionnaires -
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Wake Forest University Health Sciences

OTHER

Sponsor Role collaborator

University of Wisconsin, Madison

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Kristine Kwekkeboom, PhD, RN

Role: PRINCIPAL_INVESTIGATOR

University of Wisconsin, Madison

Sandra E Ward, PhD, RN

Role: PRINCIPAL_INVESTIGATOR

Uniuversity of Wisconsin Madison

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Aurora St. Luke's Hospital

Milwaukee, Wisconsin, United States

Site Status

Aurora West Allis

West Allis, Wisconsin, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

OS11336

Identifier Type: OTHER

Identifier Source: secondary_id

A545000

Identifier Type: OTHER

Identifier Source: secondary_id

NUR/FACULTY AFFAIRS/ADMIN

Identifier Type: OTHER

Identifier Source: secondary_id

11-86E

Identifier Type: -

Identifier Source: org_study_id